Sinovac Life Sciences Co., Ltd.
Quick facts
Marketed products
Phase 3 pipeline
- Control tetanus vaccine, adsorbed · Immunology / Infectious Disease
This vaccine stimulates the immune system to produce antibodies against tetanus toxin by presenting inactivated tetanus toxoid adsorbed onto an aluminum salt adjuvant. - Investigational tetanus vaccine, adsorbed · Immunology
An adsorbed tetanus toxoid vaccine that stimulates the immune system to produce antibodies against tetanus toxin, providing active immunization against tetanus infection.
Phase 2 pipeline
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Sinovac Life Sciences Co., Ltd. portfolio CI brief
- Sinovac Life Sciences Co., Ltd. pipeline updates RSS
Frequently asked questions about Sinovac Life Sciences Co., Ltd.
What are Sinovac Life Sciences Co., Ltd.'s marketed drugs?
Top marketed products include Prevenar13®.
What is Sinovac Life Sciences Co., Ltd.'s pipeline?
Sinovac Life Sciences Co., Ltd. has 2 drugs in Phase 3, 1 in Phase 2, 3 in Phase 1. Late-stage candidates include Control tetanus vaccine, adsorbed, Investigational tetanus vaccine, adsorbed.
Related
- Prevenar13®
- Sector hub: All tracked pharma companies